FTSE 100
9.216,67
PKT
-11,44
PKT
-0,12
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.24 | GSK Equal Weight | Barclays Capital | |
| 02.02.24 | HSBC Overweight | Barclays Capital | |
| 02.02.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.02.24 | easyJet Overweight | Barclays Capital | |
| 02.02.24 | Reckitt Benckiser Buy | UBS AG | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 01.02.24 | Diageo Underperform | RBC Capital Markets | |
| 01.02.24 | Glencore Buy | Jefferies & Company Inc. | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 01.02.24 | Unilever Overweight | Barclays Capital | |
| 01.02.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 01.02.24 | GSK Halten | DZ BANK | |
| 01.02.24 | Glencore Outperform | RBC Capital Markets | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 01.02.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 01.02.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | GSK Buy | Deutsche Bank AG | |
| 01.02.24 | easyJet Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | easyJet Sector Perform | RBC Capital Markets | |
| 31.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.01.24 | GSK Buy | UBS AG | |
| 31.01.24 | AstraZeneca Sell | UBS AG | |
| 31.01.24 | Diageo Overweight | Barclays Capital | |
| 31.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Sell | UBS AG | |
| 31.01.24 | Diageo Outperform | Bernstein Research | |
| 31.01.24 | Diageo Sell | Deutsche Bank AG | |
| 31.01.24 | Vodafone Group Buy | Deutsche Bank AG | |
| 31.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 31.01.24 | Diageo Hold | Jefferies & Company Inc. | |
| 30.01.24 | GSK Buy | UBS AG | |
| 30.01.24 | Diageo Overweight | Barclays Capital | |
| 30.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | Diageo Outperform | Bernstein Research | |
| 30.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 30.01.24 | Diageo Underperform | RBC Capital Markets | |
| 30.01.24 | Diageo Sell | UBS AG | |
| 30.01.24 | BAT Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.